Sullivan Lara - Insider Non-Derivative Transactions at Pyxis Oncology, Inc. (PYXS) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Sep 18, 2023, Sullivan Lara's relationship to Pyxis Oncology, Inc. (PYXS) is Director,Officer (President and CEO), and currently has 2,403,882 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other PYXS insiders.
Data Source: SEC.
Sullivan Lara - Insider Non-Derivative Transactions of PYXS Common Stock
Sullivan Lara - Insider Non-Derivative Transactions at PYXS
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Sep 19, 2023 | Sell -- (Common Stock) | 8541 | 2.1 | 2403882 |
| Sep 15, 2023 | Sell -- (Common Stock) | 100 | 2.25 | 2412423 |
| Sep 14, 2023 | F -- (Common Stock) | 184742 | 2.13 | 2412523 |
| Sep 14, 2023 | Sell -- (Common Stock) | 3000 | 2.27 | 2597265 |
| Sep 13, 2023 | Sell -- (Common Stock) | 4917 | 2.25 | 2600265 |
| Sep 12, 2023 | Sell -- (Common Stock) | 20000 | 2.27 | 2605182 |
| Sep 8, 2023 | Acquisition -- (Common Stock) | 469483 | 0 | 2625182 |
| Mar 25, 2023 | Acquisition -- (Common Stock) | 703379 | 0 | 2155699 |
| Jan 4, 2023 | Acquisition -- (Common Stock) | 95684 | 0 | 1452320 |